ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy
ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy aliu Wed, 05/22/2024 - 16:49
ASCO: Data detail Verzenio's flop in prostate cancer as Lilly seeks redemption via radiotherapy aliu Wed, 05/22/2024 - 16:49
Sanofi, Bristol Myers on the hook for $916M in do-over of Plavix marketing case in Hawaii kdunleavy Wed, 05/22/2024 - 15:03
Pfizer, busy with $4B savings drive, plots even more cuts out to 2027 esagonowsky Wed, 05/22/2024 - 14:11
Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China fkansteiner Wed, 05/22/2024 - 12:28
Novo Nordisk office building 'not able to be saved' after company's 2nd fire in a week zbecker Wed, 05/22/2024 - 10:47
Otsuka pulls plug on Alzheimer's agitation drug after 2nd failed trial kdunleavy Wed, 05/22/2024 - 10:28
Bristol Myers lines up Opdivo treatment in Pakistan, Rwanda and beyond as part of 10-year access campaign fkansteiner Wed, 05/22/2024 - 09:39
New NIH findings on talc use and ovarian cancer pose challenge to J&J's high-stakes defense kdunleavy Wed, 05/22/2024 - 07:14